human interferon alpha 2b / Generic mfg.  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
human interferon alpha 2b / Generic mfg.
ChiCTR-OIN-17013182: A Multicenter, Contrasted Clinical Study on Efficacy and Safety of Recombinant Human Interferonα2b Spray in the Treatment of Hand-foot-and --mouth Disease in Kids

Completed
1
313
 
rhIFNα2b spray ;ribavirin spray
Beijing Ditan Hospital Capital Medical University; Beijing Ditan Hospital Capital Medical University, Tianjin Sinobioway Biomedicine Co,. Ltd.
hand, foot and mouth disease
 
 
Recombinant human interferon alpha2b aerosol for COVID-19 treatment phase I trial, ChiCTR2200062797: A single-center,random,single-blind clinical research in SARS-CoV-2 infected patient to evaluate the effectiveness and safety by inhalating recombinant human interferon alpha2b aerosol

Not yet recruiting
1
1000
 
Inhalation of Recombinant human interferon alpha2b aerosol ;Inhalation of saline
Shanghai Public Health Clinical Center; Shanghai Public Health Clinical Center, Self-raised fund
COVID-19
 
 

Download Options